Treatment of Schamberg's disease with pentoxifylline - therapeutic trial
JPAD-Journal of Pakistan Association of Dermatologists. 2008; 18 (2): 97-99
em Inglês
| IMEMR
| ID: emr-88420
ABSTRACT
Thirty patients with Schamberg's disease were started on pentoxifylline [400 mg three times daily] for a period of 9 weeks. Improvement was assessed at 3 weekly intervals by two observers independently and graded as mild [<25%], moderate [25-50%] and marked [>50%]. Marked improvement was observed in 15/30 [50%] patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Pentoxifilina
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Pak. Assoc. Dermatol.
Ano de publicação:
2008
Similares
MEDLINE
...
LILACS
LIS